Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07841470
PHASE2/PHASE3

Corneal Crosslinking for Treatment of Progressive Keratoconus or Corneal Ectasia

Sponsor: Price Vision Group

View on ClinicalTrials.gov

Summary

This randomized study compares 2 variations of corneal crosslinking for treatment of keratoconus or corneal ectasia.

Official title: Corneal Crosslinking for Treatment of Progressive Keratoconus or Ectasia: Randomized Comparison of Pulsed vs. Non-pulsed Treatment

Key Details

Gender

All

Age Range

10 Years - 90 Years

Study Type

INTERVENTIONAL

Enrollment

500

Start Date

2025-10-01

Completion Date

2031-06-30

Last Updated

2026-09-25

Healthy Volunteers

No

Interventions

COMBINATION_PRODUCT

Riboflavin 0.1% ophthalmic solution and pulsed light

Use of riboflavin 0.1% eye drops and pulsed 18 milliwatt/cm2 ultraviolet A light for 10 minutes

COMBINATION_PRODUCT

Riboflavin 0.1% ophthalmic solution and non-pulsed light

Use of riboflavin 0.1% eye drops and non-pulsed 9 milliwatt/cm2 ultraviolet A light for 10 minutes

Locations (1)

Price Vision Group

Indianapolis, Indiana, United States